GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (WBO:CVS) » Definitions » Return-on-Tangible-Equity

CVS Health (WBO:CVS) Return-on-Tangible-Equity : Negative Tangible Equity% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is CVS Health Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. CVS Health's annualized net income for the quarter that ended in Dec. 2023 was €7,505 Mil. CVS Health's average shareholder tangible equity for the quarter that ended in Dec. 2023 was €-42,002 Mil. Therefore, CVS Health's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was Negative Tangible Equity%.

The historical rank and industry rank for CVS Health's Return-on-Tangible-Equity or its related term are showing as below:

WBO:CVS' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 486.54   Med: 486.54   Max: 486.54
Current: Negative Tangible Equity

During the past 13 years, CVS Health's highest Return-on-Tangible-Equity was 486.54%. The lowest was 486.54%. And the median was 486.54%.

WBO:CVS's Return-on-Tangible-Equity is ranked better than
94.44% of 18 companies
in the Healthcare Plans industry
Industry Median: 27.405 vs WBO:CVS: Negative Tangible Equity

CVS Health Return-on-Tangible-Equity Historical Data

The historical data trend for CVS Health's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health Return-on-Tangible-Equity Chart

CVS Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity

CVS Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity

Competitive Comparison of CVS Health's Return-on-Tangible-Equity

For the Healthcare Plans subindustry, CVS Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health's Return-on-Tangible-Equity Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where CVS Health's Return-on-Tangible-Equity falls into.



CVS Health Return-on-Tangible-Equity Calculation

CVS Health's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=7651.448/( (-29720.896+-40389.265 )/ 2 )
=7651.448/-35055.0805
=Negative Tangible Equity %

CVS Health's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=7504.728/( (-43615.476+-40389.265)/ 2 )
=7504.728/-42002.3705
=Negative Tangible Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


CVS Health  (WBO:CVS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


CVS Health Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of CVS Health's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CVS Health (WBO:CVS) Business Description

Address
One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

CVS Health (WBO:CVS) Headlines

From GuruFocus

Q1 2023 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

CVS Health to Acquire Signify Health Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024